Shetal A Patel, MD

PD-1 inhibitor monotherapy - 2 cycles after 3 PM

PD-1/PD-L1 inhibitor monotherapy - 4 cycles after 3 PM

PD-1/PD-L1 inhibitor monotherapy - 4 cycles before 12:00PM

Effects of Infusion Timing on Treatment Response in Solid Tumors

4 unique interventions1 categories

Analytics

Trial Phases

Phase 21

Trial Status

Recruiting1

Role Distribution

Principal Investigator1

PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT07630168Phase 2Recruiting

Head and Neck CancerLung CancerMetastatic Head and Neck Cancer+4 more

PrincipalinvestigatorStart date: 2026-08-03

Research Network

Collaboration Network

1 collaborators·0 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Cancer of Head and Neck1 Lung Cancer1 Metastatic Head and Neck Cancer1 Metastatic Lung Cancer1 Metastatic Squamous Cell Carcinoma1 Carcinoma, Non-Small-Cell Lung1 Resectable Head and Neck Squamous-cell Carcinoma1

Affiliations

UNC Lineberger Comprehensive Cancer Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

21 trials

Shared therapeutic areas:

Lung CancerCarcinoma, Non-Small-Cell LungCancer of Head and Neck

Similarity Score13%

Michael B Gill

Power Life Sciences Inc.

105 trials

Shared therapeutic areas:

Cancer of Head and NeckLung CancerCarcinoma, Non-Small-Cell Lung

Similarity Score13%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

74 trials

Shared therapeutic areas:

Lung CancerCarcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell LungLung Cancer

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

32 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungLung Cancer

You Lu, MD

West China Hospital

18 trials

Shared therapeutic areas:

Lung CancerCancer of Head and Neck

John D. Hainsworth, MD

SCRI Development Innovations, LLC

26 trials

Shared therapeutic areas:

Lung CancerCancer of Head and Neck

Aminah Jatoi, MD

Mayo Clinic

29 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungLung Cancer

Yongchang Zhang, MD

Hunan Cancer Hospital

27 trials

Shared therapeutic areas:

Lung CancerCarcinoma, Non-Small-Cell Lung

James L Gulley, M.D.

National Cancer Institute (NCI)

18 trials

Shared therapeutic areas:

Cancer of Head and NeckCarcinoma, Non-Small-Cell Lung

Mark Levine, MD

Ontario Clinical Oncology Group (OCOG)

13 trials

Shared therapeutic areas: